Mercy is the first and only health system to adopt continuous glucose monitor technology developed by Senseonics Holdings.
In partnership with the St. Louis-based health system and Ascensia Diabetes Care, Senseonics said in a news release it is rolling out a "first-of-its-kind relationship in a diabetes population management program."
With Mercy seeing more than 3 million patients each year, more than 30,000 Mercy patients are predicted to benefit from the med tech's products, the release said. The system's hospitals will launch the remote patient monitoring program in St. Louis first before expanding throughout Missouri, Kansas, Arkansas and Oklahoma throughout 2025.